Bulletin
Investor Alert

Beam Therapeutics Inc.

NAS: BEAM

GO
/marketstate/country/us

After Hours

/zigman2/quotes/216229751/composite

$

93.95

Change

+0.21 +0.22%

Volume

Volume 1,188

Oct 22, 2021, 5:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/216229751/composite

Previous close

$ 94.97

$ 93.74

Change

-1.23 -1.30%

Day low

Day high

$91.46

$95.91

Open
Open: 94.24

52 week low

52 week high

$32.97

$138.52

Open

Market cap

$6.30B

Average volume

639,301

P/E ratio

N/A

Rev. per Employee

$132.60

EPS

-6.95

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/beam

MarketWatch News on BEAM

  1. Prime Is the Newest Gene Editing, and It's Getting Better

    7:11 p.m. Oct. 20, 2021

    - Barron's Online

  2. Beam Therapeutics assumed at buy, up from hold, at Stifel Nicolaus

    7:55 a.m. Sept. 24, 2021

    - Tomi Kilgore

  3. Intellia Stock Is Rocketing Because of a Gene-Editing Breakthrough

    9:21 a.m. June 30, 2021

    - Barron's Online

  4. Cathie Wood's ARK Innovation Is Rebounding. She Bought the Dip.

    2:39 p.m. May 28, 2021

    - Barron's Online

  5. Biotech stocks are a buy — especially these 18 picks

    2:02 p.m. March 13, 2021

    - Michael Brush

  6. Beam Therapeutics downgraded to neutral from overweight at J.P. Morgan

    8:18 a.m. Jan. 29, 2021

    - Tomi Kilgore

  7. Beam Therapeutics initiated at hold with $84 price target at Stifel

    11:15 a.m. Jan. 6, 2021

    - Tonya Garcia

  8. These Companies Are Seeking a Cure for Sickle Cell

    11:53 a.m. July 25, 2020

    - Barron's Online

  9. Beam Therapeutics started at overweight with $31 stock price target at J.P. Morgan

    9:56 a.m. March 2, 2020

    - Tomi Kilgore

  10. Beam Therapeutics started at outperform with $32 stock price target at Wedbush

    8:58 a.m. March 2, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/beam

Other News on BEAM

  1. 2 Gene-Editing Stocks to Have on Your Radar Right Now

    9:01 a.m. Oct. 17, 2021

    - Motley Fool

  2. Got $500? 3 Game-Changing Stocks to Buy Right Now

    5:55 a.m. Oct. 4, 2021

    - Motley Fool

  3. 3 Most Overvalued Biotech Stocks on the Market Right Now

    6:14 a.m. Oct. 1, 2021

    - Motley Fool

  4. Editas (EDIT) Down on Initial Data From Eye Disease Study

    10:37 a.m. Sept. 30, 2021

    - Zacks.com

  5. Breaking Down CRISPR Technology

    6:45 a.m. Sept. 28, 2021

    - Motley Fool

  6. Loading more headlines...
/news/pressrelease/company/us/beam

Press Releases on BEAM

  1. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.